Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients

AIM OF THE STUDY: Sunitinib-related side effects may develop as a result of the pharmacokinetic pathway affects the of the drug. MATERIAL AND METHODS: Data on mRCC patients were obtained from the hospital archives. Outcomes of patients were evaluated in terms of related prognostic factors, sunitinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Ordu, Çetin, Pilanci, Kezban N., Avcı, Nilüfer, Yıldız, İbrahim, Alço, Gül, Demirhan, Özkan, Köksal, Ülkühan I., Elbüken, Filiz, Tecimer, Coskun, Demir, Gökhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925734/
https://www.ncbi.nlm.nih.gov/pubmed/27358594
http://dx.doi.org/10.5114/wo.2016.60069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925734/
https://www.ncbi.nlm.nih.gov/pubmed/27358594
http://dx.doi.org/10.5114/wo.2016.60069

Ejemplares similares